 Home > Active Ingredient News > Digestive System Information > IBD: Intestinal ultrasound assessment of longitudinal bowel behavior predicts early response to anti-TNF therapy in patients with Crohn's disease

IBD: Intestinal ultrasound assessment of longitudinal bowel behavior predicts early response to anti-TNF therapy in patients with Crohn's disease

 Last Update: 2022-04-21
 Source: Internet
 Author: User

Tags

2 crucial

study chemistry college

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Anti-tumor necrosis factor (TNF)-alpha drugs, such as infliximab, are widely used to treat CD patients
.

It is especially indicated for patients with relapse, severe disease activity and poor prognosis

Anti-tumor necrosis factor (TNF)-alpha drugs, such as infliximab, are widely used to treat CD patients

Of the 30 patients included in this study, 20 responded to anti-TNF therapy at week 14
.

Compared with the non-responder group, the intestinal wall thickness and SWE value of the responder group were significantly decreased (P = 0.

Figure: Schematic diagram of ultrasound

This preliminary study shows that researchers can predict CD patients' treatment response by assessing changes in bowel ultrasound behavior as early as 2 weeks after starting anti-TNF therapy
.

Intestinal ultrasound and elastography predict early response to anti-TNF therapy

This preliminary study shows that researchers can predict CD patients' treatment response by assessing changes in bowel ultrasound behavior as early as 2 weeks after starting anti-TNF therapy

Yu-Jun Chen.

Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients with Crohn's Disease: A Pilot Study Get access Arrow.
Leave a Comment here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Raw Material Powder 99% White Powder CAS 474-25-9 Chenodeoxycholic Acid

CAS No.: 474-25-9

Pharmacy Grade

$4-5/G FOB

Highest Quality CAS 119141-88-7 Esomeprazole powder 99% in Stock Fast Delivery

CAS No.: 119141-88-7

Pharmacy Grade

$4-5/G FOB

Wholesale Magnesium Oxide Raw Materials CAS 1309-48-4 99% Powder Evergreen EGC-Magnesium Oxide Powder

CAS No.: 1309-48-4

Food Grade

$70-76/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.